Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials

Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials

Background Currently, there is no head-to-head comparison of novel pharmacological treatments for heart failure with reduced ejection fraction (HFrEF). A network meta-analysis aimed to compare effects of both conventional and alternative drug combinations on time to develop primary composite outcome...

Full description

Bibliographic Details
Main Authors: Ammarin Thakkinstian, Amarit Tansawet, Teerapat Yingchoncharoen, Pawin Numthavaj, Thanakit Suebsaicharoen, Puri Chunekamrai, Thanaphruet Issarawattana
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/10/2/e002364.full

Internet

https://openheart.bmj.com/content/10/2/e002364.full

Similar Items